Healthcare -
Biotechnology - NASDAQ - US
$ 18.05
2.67 %
$ 1.24 B
Market Cap
-3.77
P/E
ARVN - STOCK-BASED COMPENSATION
Stock-based Compensation ARVN - Arvinas, Inc.
71.6 M
LAST VALUE
11.98%
2 YEAR CAGR
43.83%
5 YEAR CAGR
0.00%
10 YEAR CAGR